Acute leukemia diagnosis during the COVID-19 pandemic
Panminerva Med
.
2023 Mar;65(1):93-94.
doi: 10.23736/S0031-0808.21.04618-8.
Epub 2022 Jun 28.
Authors
Luca Guarnera
1
,
Elisa Buzzatti
2
,
Francesco Marchesi
3
,
Daniele Armiento
4
,
Carla Mazzone
5
,
Saveria Capria
6
,
Emilia Scalzulli
6
,
Francesco Malfona
6
,
Sabina Chiaretti
6
,
Raffaele Palmieri
2
,
Giovangiacinto Paterno
2
,
Chiara Franzese
2
,
Fabrizio Bonanni
2
,
Arianna Savi
2
,
Gianmario Pasqualone
2
,
Federico Moretti
2
,
Luca Maurillo
2
,
Francesco Buccisano
2
,
Adriano Venditti
2
,
Maria Ilaria Del Principe
2
Affiliations
1
Department of Biomedicine and Prevention, Tor Vergata Univerisity, Rome, Italy - lucaguarnera@live.com.
2
Department of Biomedicine and Prevention, Tor Vergata Univerisity, Rome, Italy.
3
Unit of Hematology and Stem Cell Transplant, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
4
Unit of Hematology, Stem Cell Transplantation, Campus Bio-Medico University, Rome, Italy.
5
Unit of Hematology, Department of Medical Area, St. Eugenio Hospital, ASL Roma2, Rome, Italy.
6
Unit of Hematology, Department of Translational and Precision Medicine, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy.
PMID:
35762359
DOI:
10.23736/S0031-0808.21.04618-8
No abstract available
MeSH terms
Acute Disease
COVID-19 Testing
COVID-19*
Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / epidemiology
Leukemia, Myeloid, Acute* / therapy
Pandemics
Retrospective Studies